

You're on treatment, your symptoms have eased, and you're starting to feel like yourself again. That matters, and it should be celebrated.
But here's the question most Inflammatory Bowel Disease (IBD) patients never think to ask: is the inflammation inside my gut actually healing, or just going quiet?
Remission is not a single destination. It's a long-term journey. From symptom relief on the surface to genuine tissue healing underneath. If you're living with ulcerative colitis (UC) or Crohn's disease (CD), understanding where you sit on that journey is one of the most powerful things you can do for your future.

Clinical remission is the stage most patients recognise: day-to-day symptoms such as pain, bleeding, or frequent bowel movements have reduced to a manageable level or have disappeared.
A great first milestone.1
But a significant proportion of patients whose symptoms improve still have active inflammation visible during endoscopy. This "silent inflammation" can drive flare-ups, disease progression, and long-term complications.1
That's why the latest research defines treatment targets that go beyond how you feel, aiming for healing goals you can objectively measure, not just relief you can sense.
The latest international STRIDE-II guidelines set out the gold standards of care for people living with ulcerative colitis (UC) or Crohn's disease (CD). Each stage represents a deeper level of healing. Not everyone will reach every stage — but understanding these targets puts you in a stronger position to advocate for the care that gives you the most freedom.2
Your day-to-day symptoms have meaningfully improved.
For UC, this means a significant reduction in rectal bleeding and stool frequency.
For CD, a reduction in abdominal pain and diarrhoea. This is the immediate goal of any treatment and the stage most patients recognise as "remission."
Patient-reported symptoms.
For UC: no rectal bleeding, fewer than 3 bowel movements per day.2
For CD: no abdominal pain, normalised stool frequency. Assessed at every clinic visit.2
Your body's inflammation markers have returned to acceptable levels.
This is a sign that the underlying immune response is calming down, even beyond what you can feel.
Biomarkers are an important "early warning system" — they can flag rising inflammation before symptoms return.
Blood test:
C-reactive protein (CRP) normalisation.2
Stool test:
Faecal calprotectin falling to acceptable levels. Non-invasive and can be monitored regularly between endoscopies.2
The lining of your gut shows no visible ulcers, erosions, or active inflammation when examined during an endoscopy.
The point where your gastroenterologist can confirm that healing is occurring at the tissue level. Endoscopic healing is associated with fewer relapses, reduced need for steroids, and better long-term outcomes.
Colonoscopy or sigmoidoscopy.
Evidence-based, objective measure.23
For CD, remission looks for a Simple Endoscopic Score (SES-CD) showing absence of ulceration. While UC patients will look for a Mayo Endoscopic Subscore of 0–1.23
For people with ulcerative colitis, this is the deepest level of remission currently measurable.
Histological healing means that tissue samples (biopsies) taken during endoscopy show no microscopic evidence of inflammation, even when the gut surface appears normal to the naked eye. Achieving histological remission is associated with a lower risk of relapse and may reduce long-term complications, including colorectal cancer risk.
Microscopic examination of mucosal biopsies.
Pathologists assess for residual inflammatory infiltrate, crypt architecture distortion, and other microscopic markers of ongoing disease activity. Emerging as the gold standard of deep remission in UC.2
For people with Crohn's disease, this stage goes even deeper.
Transmural healing means that the inflammation has resolved not just on the surface of the gut lining, but through the full thickness of the bowel wall. Because CD can affect all layers of the intestinal wall, this is considered a measure of deeper disease control.
Cross-sectional imaging.
MRI enterography or intestinal ultrasound, assessing bowel wall thickness and deeper inflammation beyond what endoscopy can see.45
If silent inflammation is the risk, and endoscopic remission or beyond is the goal, monitoring is the answer.
Below are the tools your doctor and healthcare teams can use to help you track your progress.
Measures general inflammation. Not gut-specific, but rising CRP in IBD can signal increasing disease activity. Used alongside calprotectin for a fuller picture.2
The most direct assessment of your gut lining. Inspects for ulcers, redness, and erosions. Scoring systems — Mayo (UC) and SES-CD (CD) — standardise what healing looks like.36
Non-invasive imaging assessing bowel wall thickness and deeper inflammation. Particularly relevant for Crohn's disease and transmural healing.2
Read our patient conversation guide, designed to help you ask your doctor the right questions with confidence.









